Fluorapacin

氟莱哌素

Report date: 2026/01/27 10:54:48
NME

Base Information

Drug NameFluorapacin
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAgilent Biosciences (Hangzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesAgilent Biosciences (Hangzhou) Co Ltd
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A